United Kingdom-Edinburgh: Recombinant Quadrivalent Influenza Vaccine (Supemtek)

Type of document: Contract Notice
Country: United Kingdom
Publication Ref: (2021/S 000-019755/EN)
Nature of contract: Supply contract
Procedure: Negotiated without a call for competition
Type of bid required: Not applicable

Voluntary ex ante transparency notice
Supplies

Section I: Contracting authority
I.1) Name and addresses
Official name: The Common Services Agency (more commonly known as NHS National Services Scotland) (“NSS”)
Postal address: Gyle Square (NSS Head Office), 1 South Gyle Crescent
Town: Edinburgh
Postal code: EH12 9EB
Country: United Kingdom
Contact Person: Laura Ferguson
Telephone: +44 1312756725
Email: laura.ferguson7@nhs.scot
Internet address(es):
Main address:
Address of the buyer profile:

I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health

Section II: Object
II.1) Scope of the procurement
II.1.1) Title: Recombinant Quadrivalent Influenza Vaccine (Supemtek)

Reference number: NP93821d
II.1.2) Main CPV code: 33651660
II.1.3) Type of contract Supplies
II.1.4) Short Description:
This procurement is for the supply of recombinant quadrivalent influenza vaccine (Supemtek) to NHSScotland for use in the annual seasonal influenza immunisation programme.
II.1.6) Information about lots
The contract is divided into lots: no
II.1.7) Total value of the procurement(excluding VAT)
Value:2257600
Currency:GBP
II.2) Description
II.2.2)Additional CPV code(s)
Main CPV code: 33651660

II.2.3) Place of performance
Nuts code: Main site or place of performance:Movianto, Unit1, Haydock Green, PennyLane, Haydock, WA119DT

II.2.4) Description of the procurement
This procurement is for the supply of recombinant quadrivalent influenza vaccine (Supemtek) for use in the annual seasonal influenza immunisation programme.

II.2.5) Award criteria
II.2.11) Information about options
Options: no
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Negotiated procedure without prior publication(in accordance with Article 32 of Directive 2014/24/EU)
IV.1.8) Information about the Government Procurement Agreement(GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2) Administrative information

Section V: Award of contract/concession
Contract No: NP93821d
V.2) Award of contract/concession
V.2.1) Date of conclusion of the contract/concession award decision:2021-08-13
V.2.2) Information about tenders
V.2.3) Name and address of the contractor
Official name: Aventis Pharma Ltd t/a Sanofi
Postal address: One Onslow Street
Town: Guildford
Postal code: GU1 4YS
Country: United Kingdom
Nuts code:
The contractor is an SME: no

V.2.4) Information on value of the contract/lot/concession(excluding VAT)
for framework agreements – total maximum value for this lot
for contracts based on framework agreements, if required – value of contract(s) for this lot not included in
previous contract award notices

Section VI: Complementary information
VI.3) Additional information:
The total value in Sections II.1.7 and V.2.4 refers to the nine (9) duration of the Contract.
(SC Ref:663319)
VI.4) Procedures for review
VI.4.1) Review body
Official name: Sheriff Court House
Postal address: 27 Chambers Street
Town: Edinburgh
Postal code: EH1 1LB
Country: United Kingdom
Telephone: +44 1312252525
E-mail: edinburgh@scotcourts.gov.uk

VI.4.3) Review procedure
Precise information on deadline(s) for review procedures:
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:
An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts(Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.

VI.5) Date of dispatch of this notice:
2021-08-13

Justification for the award of the contract without prior publication of a call for
competition in the Official Journal of the European Union
1.Justification for the choice of the negotiated procedure without prior publication of a call for competition in accordance with Article
32 of Directive 2014/24/EU
The works, supplies or services can be provided only by a particular economic operator for the following reason:
absence of competition for technical reasons

3.Explanation
Please explain in a clear and comprehensive manner why the award of the contract without prior publication in the Official Journal of the European Union
is lawful, by stating the relevant facts and, as appropriate, the conclusions of law in accordance with the directive:
Aventis Pharma t/a Sanofi are currently the only supplier of recombinant quadrivalent influenza vaccine (Supemtek) for which no direct competition exists.